Abstract：【Objective】To investigate the efficacy of early nourishing enteral nutrition in patients with severe cerebral infarction. 【Methods】A total of 72 patients with severe cerebral infarction admitted from February 2020 to December 2022 were divided into the control group and the observation group according to random number table method, with 36 patients in each group. Patients in the control group received conventional treatment, while those in the observation group underwent early nourishing enteral nutrition therapy in addition to conventional treatment. The cognitive function, immune function, rehabilitation effect and adverse reactions were compared between the two groups before and after treatment.【Results】After treatment, the orientation score, language ability score, calculation ability score, attention score, and memory score of the two groups were higher than those before treatment, and the observation group was higher than the control group, with statistically significant differences (P<0.05). After treatment, the CD3+ and CD4+/CD8+ levels of the two groups were higher than those before treatment, and the observation group was higher than the control group, with statistically significant differences (P<0.05). After treatment, the Glasgow Coma Scale(GCS) scores of the two groups were higher than those before treatment, while the National Institute of Health stroke scale(NIHSS) scores were lower than those before treatment. The GCS score of the observation group was higher than that of the control group, and the NIHSS score was lower than that of the control group, with statistically significant differences (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group, with statistically significant differences (P<0.05). 【Conclusion】Early nourishing enteral nutrition in the treatment of severe cerebral infarction can enhance the immune function of patients, improve the cognitive function, promote the rehabilitation of patients, improve neurological function, and reduce the incidence of adverse reactions.
马凌, 刘巧艳. 早期滋养型肠内营养在重症脑梗死患者中的应用效果[J]. 医学临床研究, 2025, 42(1): 53-55.
MA Ling, LIU Qiaoyan. Application of Early Nourishing Enteral Nutrition in Patients with Severe Cerebral Infarction. JOURNAL OF CLINICAL RESEARCH, 2025, 42(1): 53-55.
[1] BAO L, ZHANG S Y, GONG X Y, et al. Trousseau syndrome related cerebral infarction: clinical manifestations, laboratory findings and radiological features[J].J Stroke Cerebrovasc Dis,2020,29(9):104891. [2] CHEN J H, LI M C, ZHU X, et al. Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults[J].Aging (Albany NY),2020,12(3):2939-2951. [3] HEALY R J, ZORRILLA-VACA A, ZIAI W, et al. Glasgow coma scale score fluctuations are inversely associated with a NIRS-based index of cerebral autoregulation in acutely comatose patients[J].J Neurosurg Anesthesiol,2019,31(3):306-310. [4] 王洁霞,王园园,孟琳琳. 早期不同肠内营养剂支持在重症脑梗死病人中的应用效果[J].中西医结合心脑血管病杂志,2022,20(2):333-336. [5] 刘瑜琳. 重症脑梗死患者肠内营养期间胃潴留发生率及影响因素分析[J].中国民康医学,2021,33(16):102-103. [6] 蒙陶莎,韦琳,李先锋. 对重症脑梗死患者早期肠内营养治疗临床疗效的分析[J].人人健康,2020,54(4):91. [7] 中国中西医结合学会急救医学专业委员会. 中国急性缺血性脑卒中中西医急诊诊治专家共识[J].中华危重病急救医学, 2018, 30(3):193-197. [8] 郭发瑞,郭囡,兀瑞俭,等.重症脑梗死患者血清中miR-206和miR-210的表达变化及临床意义[J].中国实验诊断学, 2024, 28(3):273-276. [9] 张广波,殷小芳,徐丽华,等. 高危非致残性脑梗死患者出院6个月内卒中复发的危险因素[J].中国神经免疫学和神经病学杂志, 2022, 29(3):230. [10] 陈翠,郭伟,王黎,等.影响急性脑梗死行机械取栓术后入住ICU患者预后的危险因素分析[J].中国中西医结合急救杂志,2023,30(3):308-312. [11] 麻银萍,黄培,叶晓晨. 中医护理干预结合肠内营养护理对重症脑梗死营养指标及生活质量的效果[J].实用中医内科杂志,2023,37(1):110-112. [12] 吴润明,孙玉宝,焦亚洲. 早期肠内整蛋白型、短肽型营养剂支持对重症脑梗死患者营养状况及外周血Th17/Treg的干预作用[J].淮海医药,2022,40(6):616-619. [13] 李龙恒,王洁. 早期肠内营养支持在重症脑梗死患者治疗中的应用观察[J].临床研究,2022,30(11):84-87. [14] 潘习,王稚,黄盛. 重症脑卒中患者早期滋养型肠内营养流程的制订与应用[J].中华护理杂志,2022,57(19):2309-2316. [15] 王云荣. 早期肠内营养支持在重症脑梗死患者治疗中的应用研究[J].智慧健康,2022,8(12):127-129.
2025, Vol. 42 
